TrialProceedings of the National Academy of Sciences of the United States of America2019

Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk.

Katarina Tengvall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.